Researchers explored the effects of opioid-sparing multimodal anesthesia embedded within an ERAS protocol on postoperative recovery in gynecologic oncologic surgery.

Researchers sought to determine whether fixed-duration treatment with venetoclax + obinutuzumab/ibrutinib would have similar efficacy to continuous ibrutinib therapy in CLL.

Survivors of nearly all types of adolescent and young adult cancer have an increased risk for developing a subsequent primary neoplasm, according to a study pub ...